Lorynn Teela

49 Scoping review pediatric patient engagement Supplement 2 - (continued) First author Year Country N Disease group Age (min) Age (max) Used method* Setting Fallon [76] 2008 United Kingdom 7 Oncology 14 23 2 Intervention development Farjou [77] 2014 Canada 200 Oncology 12 20 7 Clinical care Ford [78] 2011 Australia 10 Surgery 6 12 1 Clinical care Forsner [79] 2005 Sweden 7 Hospital admission 7 10 1 Clinical care Foster [80] 2019 New Zealand 26 Hospital admission 5 15 3 Clinical care Francis [81] 1988 United States 7 Multiple disease groups 12 16 8 Clinical care Freeman [82] 2000 United States 7 Oncology 5 15 1,2 Clinical care Gaab [83] 2013 New Zealand 7 Palliative care 9 18 6 Clinical care Gagnon [84] 2008 Canada 15 Head / brain injury 12 16 1 Clinical care Garth [85] 2009 Australia 10 Head / brain injury 8 12 1 Clinical care Geehan [86] 2003 United Kingdom 1 Oncology 17 17 8 Clinical care Gibson [87] 2009 New Zealand 23 Oncology 12 22 2 Clinical care Gibson [88] 2010 United Kingdom 38 Oncology 4 19 1,2,3,8 Clinical care Gillies [89] 2001 United Kingdom 351 Surgery 12 18 1 Clinical care Gillis [90] 1990 Canada 30 Surgery 6 12 1 Clinical care Gilljam [91] 2016 Sweden 20 Juvenile Idiopathic Arthritis 8 17 1,2 Clinical care Gonzalez-Morkos [92] 2011 United States 6 Oncology 15 18 8 Clinical care Grant [93] 2019 Canada 25 Gastrointestinal diseases 11 35 2,8 Research Grinyer [94] 2009 United Kingdom 28 Oncology 16 24 1 Clinical care Grover [95] 2013 India 12 Asthma 7 12 1 Clinical care Haase [96] 2020 United States 14 Transplantation 13 22 1 Clinical care Haase [97] 1994 United States 7 Oncology 5 18 1 Clinical care Hall [98] 2001 United States 34 Multiple disease groups 8 22 1 Research Hall [99] 2012 United Kingdom 17 Surgery 8 17 1,3,8 Clinical care Han [100] 2011 China 29 Oncology 7 14 1 Clinical care 2

RkJQdWJsaXNoZXIy MTk4NDMw